Key result
Early, staged PCI of non-culprit lesions in STEMI patients was associated with lower out-of-hospital MACE (9.3% vs 23.9%, P=0.037) but higher in-hospital MACE (20.3% vs 10.8%, P=0.186).
Why the study?
Does early, staged PCI of non-culprit lesions reduce MACE in patients with STEMI and multivessel CAD treated by primary angioplasty?
Population
110 patients with ST elevation myocardial infarction and multivessel coronary artery disease treated by…
Comparison
Early, staged percutaneous coronary intervention… vs Primary angioplasty without early, staged PCI of…
Design
Cohort
Follow-up
mean 13 months (392 +/- 236 days)
Authors
Loading...
Should not yet change practice in STEMI with multivessel disease; leaves open the net benefit of staged non-culprit PCI for randomized confirmation.
Cohort (n=110)
Does early, staged PCI of non-culprit lesions reduce MACE in patients with STEMI and multivessel CAD treated by primary angioplasty?
Absolute Event Rate: 9.3% vs 23.9%
p-value: p=0.037
Early staged PCI of non-culprit lesions in STEMI patients with multivessel disease reduces long-term MACE but is associated with increased in-hospital periprocedural myocardial infarction.
Rigattieri et al. (2007) conducted a cohort in ST elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD) (n=110). Early, staged PCI of non-culprit lesions vs. Primary angioplasty without early, staged PCI was evaluated on Out of hospital MACE (composite of death, stroke, stent thrombosis, any coronary revascularization, and re-hospitalization for acute coronary syndrome) (p=0.037). Early, staged PCI of non-culprit lesions in STEMI patients was associated with lower out-of-hospital MACE (9.3% vs 23.9%, P=0.037) but higher in-hospital MACE (20.3% vs 10.8%, P=0.186).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: